Disaster Medicine Fellowship Director at the University of Massachusetts
Review of the scope, epidemiology, background and types of emerging infectious diseases
Discuss past pandemics and their implications for the future
Analyze how COVID-19 fits into the overall schema of disaster medicine and human populations
Dr. Andrew Milsten, Disaster Medicine fellowship director. Dr. Milsten received his MD from the George Washington University, completed his residency in Emergency Medicine at the Lincoln Medical Center in New York City. He completed an EMS Fellowship in addition to a Masters of Science in Emergency Health Services at the University of Maryland. He has been active as a clinician and researcher since 2000 at the University of Maryland School of Medicine and at Baltimore Washington Medical Center. His research has primarily focused on mass gathering medicine, while he was director for special events & Ravens stadium fan operations. He joined the UMass Emergency Medicine Residency Program and faculty in 2009 and is director of the Fellowship in Disaster Medicine and Emergency Management. Dr. Milsten coordinates and runs the NDLSF training programs at UMass, specifically BDLS and ADLS. He was also instrumental in organizing and founding the New England Society of Disaster Medicine (NESDM).
Accreditation Statement: The Beacon Health System is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.
Designation Statement: Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure: Physician(s) and all planners associated with this activity do not have any potential conflict of interest.
Disclosure Statement: As a CME provider accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs. All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufactures, or other corporations whose products or services are related to the subject matter of the presentation topic.
Commercial Support: No commercial support was used in planning or implementation of the CME activity.
On Demand Details: Recordings are available for credit until 3/3/2022
Questions may be directed to Jenai White at 574.647.7691 or email@example.com